Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Cerefolin®/CerefolinNAC® on Biomarker Measurements in Patients With Mild Cognitive Impairment, Alzheimer's Disease and Related Disorders

NCT01745198 is registered in ClinicalTrials.gov with Pamlab, Inc. as lead sponsor.

NCT NCT01745198
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01745198 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Cerefolin®/CerefolinNAC® on Biomarker Measurements in Patients With Mild Cognitive Impairment, Alzheimer's Disease and Related Disorders
Lead sponsor
Pamlab, Inc.
Phase
Observational
Overall status
Completed
Start date
December 31, 2012
Completion date
June 30, 2014
Enrollment
121 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease, alzheimer's disease related disorders, mild cognitive impairment